tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CRVS Stock Latest News

Corvus initiates placebo-controlled phase 1 soquelitinib clinical trial
The FlyCorvus initiates placebo-controlled phase 1 soquelitinib clinical trial
16d ago
CRVS
Corvus Pharmaceuticals Announces Initiation of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
PremiumPress Releases
Corvus Pharmaceuticals Announces Initiation of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
16d ago
CRVS
Corvus Pharmaceuticals: Insider Ownership Raises Power Concentration Concerns
PremiumCompany Announcements
Corvus Pharmaceuticals: Insider Ownership Raises Power Concentration Concerns
1M ago
CRVS
Corvus Pharmaceuticals price target lowered to $7 from $8 at Oppenheimer
PremiumThe Fly
Corvus Pharmaceuticals price target lowered to $7 from $8 at Oppenheimer
1M ago
CRVS
Corvus to initiate Phase 1 trial of soquelitinib for AD in Q2
PremiumThe Fly
Corvus to initiate Phase 1 trial of soquelitinib for AD in Q2
1M ago
CRVS
Corvus Pharmaceuticals reports Q4 EPS (14c) vs. (21c) last year
PremiumThe FlyCorvus Pharmaceuticals reports Q4 EPS (14c) vs. (21c) last year
1M ago
CRVS
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
PremiumPress Releases
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
1M ago
CRVS
Options Volatility and Implied Earnings Moves Today, March 19, 2024
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 19, 2024
1M ago
TME
ZTO
Corvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2023 Financial Results on March 19, 2024
PremiumPress Releases
Corvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2023 Financial Results on March 19, 2024
1M ago
CRVS
CRVS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
CRVS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
CRVS
Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data at the Keystone Symposia on Systemic Autoimmune and Autoinflammatory Diseases
PremiumPress Releases
Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data at the Keystone Symposia on Systemic Autoimmune and Autoinflammatory Diseases
2M ago
CRVS
Corvus Pharmaceuticals presents preclinical data for soquelitinib
PremiumThe Fly
Corvus Pharmaceuticals presents preclinical data for soquelitinib
2M ago
CRVS
FDA grants Corvus Pharmaceuticals’ Soquelitinib ODD for PTCL treatment
PremiumThe FlyFDA grants Corvus Pharmaceuticals’ Soquelitinib ODD for PTCL treatment
3M ago
CRVS
Corvus Pharmaceuticals’ treatment of T-cell lymphoma gets FDA orphan designation
PremiumThe Fly
Corvus Pharmaceuticals’ treatment of T-cell lymphoma gets FDA orphan designation
3M ago
CRVS
Corvus Pharmaceuticals Announces the Passing of Board Member Edith P. Mitchell
PremiumPress Releases
Corvus Pharmaceuticals Announces the Passing of Board Member Edith P. Mitchell
3M ago
CRVS
Cantor Fitzgerald healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald healthcare analysts hold an analyst/industry conference call
4M ago
JNJ
AFMD
Cantor Fitzgerald healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald healthcare analysts hold an analyst/industry conference call
4M ago
JNJ
AFMD
Corvus announced new interim data from Phase 1/1b trial of soquelitinib
PremiumThe Fly
Corvus announced new interim data from Phase 1/1b trial of soquelitinib
5M ago
CRVS
Corvus Pharmaceuticals
PremiumThe Fly
Corvus Pharmaceuticals
5M ago
CRVS
Corvus Pharmaceuticals Presents New Interim Soquelitinib Data from its Phase 1/1b T Cell Lymphoma Trial
PremiumPress ReleasesCorvus Pharmaceuticals Presents New Interim Soquelitinib Data from its Phase 1/1b T Cell Lymphoma Trial
5M ago
CRVS
Cantor Fitzgerald healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald healthcare analysts hold an analyst/industry conference call
5M ago
JNJ
AFMD
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2023 Financial Results
PremiumPress Releases
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2023 Financial Results
6M ago
CRVS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >